Advarra整合了研究启动和IRB技术，实现了临床试验站点激活的空前可见性-动脉网

Advarra Integrates Study Startup and IRB Technologies, Enabling Unprecedented Visibility into Clinical Trial Site Activation

CISION 等信源发布 2025-04-17 20:59



可切换为仅中文







New Release of Advarra's Study Collaboration Solution Provides Sponsors and CROs a Single View into the Progress of Site Activation Milestones and IRB Review Status Across Sites

Advarra研究协作解决方案的新版本发布，为申办方和合同研究组织（CRO）提供了一个统一的视图，以便查看各研究中心的启动里程碑进度和伦理审查委员会（IRB）审查状态。

COLUMBIA, Md.

哥伦比亚，马里兰州

，

April 17, 2025

2025年4月17日

/PRNewswire/ --

Advarra

阿德瓦拉

, the market leader in regulatory reviews and clinical research technology, today announced the integration of its electronic institutional review board (eIRB) system,

，监管审查和临床研究技术的市场领导者，今天宣布了其电子机构审查委员会 (eIRB) 系统的集成，

Center for IRB Intelligence

IRB情报中心

(CIRBI®), with its

(CIRBI®)，以其

Study Collaboration

学习合作

solution, a single-sign-on-enabled software that guides sites through the activation process and improves enrollment planning and tracking. This first-of-its-kind integration creates an automated link between IRB review status and clinical trial startup workflows, giving sponsors and CROs centralized visibility into the status of site activation—from site selection to first-patient-in (FPI)..

解决方案，一种启用单点登录的软件，引导站点完成激活过程，并改进注册规划和跟踪。这种前所未有的集成在伦理审查委员会（IRB）审查状态和临床试验启动工作流程之间创建了自动化的链接，为申办者和合同研究组织（CRO）提供了从站点选择到首例患者入组（FPI）的站点激活状态的集中可见性。

Already, more than 14,000 sites worldwide rely on Advarra's Study Collaboration solution to accelerate study startup activities such as feasibility assessments, document exchange and communication, and study training on sponsored trials. With the latest release of Study Collaboration, sponsors and CROs gain a single view into how their sites are progressing through each startup milestone, including IRB review status.

目前，全球已有超过14,000个站点依赖Advarra的Study Collaboration解决方案，以加速研究启动活动，如可行性评估、文件交换与沟通以及赞助试验的研究培训。通过最新发布的Study Collaboration，申办方和合同研究组织（CRO）能够获得一个统一的视图，查看各站点在每个启动里程碑上的进展情况，包括伦理审查委员会（IRB）的审查状态。

As site staff complete each task in the solution, progress against milestones is automatically populated. The added transparency gives sponsors and CROs a more accurate picture of their study's progress, while reducing manual tasks and redundant status checks for sites and study teams alike..

随着现场工作人员完成解决方案中的每个任务，针对里程碑的进度会自动更新。这种增加的透明度让申办方和合同研究组织 (CRO) 更准确地了解研究进展，同时减少了现场和研究团队的手动任务和冗余状态检查。

'With Advarra's IRB services supporting over 60% of clinical trials in

“凭借Advarra的IRB服务支持超过60%的临床试验，

North America

北美

, we are uniquely positioned to provide sponsors and CROs with greater visibility into site activation,' said

`,我们能够为赞助商和合同研究组织提供更深入的现场激活可视性,`说

Ashley Davidson

艾希礼·戴维森

, Vice President, Product Lead of Sponsor Tech Strategy at Advarra. 'By automating IRB review status updates and embedding them directly into Study Collaboration's milestone tracking capabilities, we have replaced the need for spreadsheets and disconnected systems—empowering study teams to oversee every critical step as it happens and offer faster, more targeted support to sites preparing for enrollment.

Advarra赞助技术战略产品主管，副总裁。“通过自动化的IRB审查状态更新，并将其直接嵌入到研究协作的里程碑跟踪功能中，我们已经取代了电子表格和分散系统的需求——使研究团队能够实时监督每一个关键步骤，并为准备招募的站点提供更快、更有针对性的支持。

At the same time, these enhancements ease the administrative burden on sites by streamlining manual tasks and reducing redundant status checks.'.

同时，这些增强功能通过简化手动任务和减少冗余的状态检查，减轻了站点的管理负担。

Mark Morais

马克·莫莱斯

, President and COO of Clinical Development at Fortrea, added: 'We are continuously improving the study startup process to reduce the administrative burden for sites and give sponsors better visibility into trial timelines. It's encouraging to see Advarra launch enhancements to its study startup software that centralize visibility into the progress of startup milestones, eliminating the need for sites to manually track and report on their progress.'.

Fortrea临床开发部总裁兼首席运营官补充道： “我们正在不断改进研究启动流程，以减轻研究中心的管理负担，并让申办方更好地了解试验时间表。看到Advarra推出对其研究启动软件的增强功能，集中展示启动里程碑的进展情况，消除站点手动跟踪和报告进度的需求，这令人备受鼓舞。”

注册参加最新版本的现场演示

Join Advarra's study startup experts for a live demo of the latest release of the Study Collaboration solution on

加入Advarra的研究启动专家团队，现场演示最新发布的Study Collaboration解决方案。

Thursday, May 8, 2025

2025年5月8日，星期四

at 1:00 –

在1:00——

1:30 pm ET

下午1点30分（东部时间）

/ 10:00 –

10:30 am PT

上午10点30分（太平洋时间）

. See how Advarra's study startup and IRB technologies integrate to deliver better visibility within its milestone tracking capability. Register for the 30-minute live demo using this link:

了解Advarra的研究启动和IRB技术如何整合，以在其里程碑跟踪功能中提供更好的可见性。通过此链接注册参加30分钟的现场演示：

https://www.advarra.com/open-demo-ssu/

。

About Advarra

关于Advarra

Advarra breaks the silos that impede clinical research, aligning patients, sites, sponsors, and CROs in a connected ecosystem to accelerate trials. Advarra is number one in research review services, site and sponsor technology, and clinical trial experience software and is trusted by the top 50 global biopharma sponsors, top 20 CROs, and 50,000 site investigators worldwide.

Advarra 打破了阻碍临床研究的壁垒，将患者、研究中心、赞助商和合同研究组织（CRO）整合到一个互联互通的生态系统中，以加速临床试验进程。Advarra 在研究审查服务、研究中心与赞助商技术以及临床试验经验软件领域位居第一，受到全球前50大生物制药赞助商、前20大CRO以及全球50,000名现场研究人员的信赖。

Advarra solutions enable collaboration, transparency, and speed needed to optimize trial operations, ensure patient safety and engagement, and reimagine clinical research while improving compliance. For more information, visit .

Advarra 解决方案能够实现优化试验操作、确保患者安全与参与以及在提高合规性的同时重新构想临床研究所需的协作、透明度和速度。欲了解更多信息，请访问。

advarra.com

。

SOURCE Advarra

来源：Advarra

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM？

440k+

44万+

Newsrooms &